This new 464-page report from Venture Planning Group provides analysis of the global clinical chemistry and immunodiagnostic markets, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers.
The report presents:
Estimated numbers of clinical chemistry immunodiagnostic testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.
Overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products.
Current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.
Strategic assessments of major suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 464 pages and 48 tables